Singapore - English - HSA (Health Sciences Authority)

medochemie singapore pte. ltd. - norfloxacin - tablet, film coated - 400 mg

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - leflunomide, quantity: 20 mg - tablet, film coated - excipient ingredients: lactose monohydrate; maize starch; povidone; colloidal anhydrous silica; magnesium stearate; crospovidone; hypromellose; macrogol 8000; titanium dioxide; purified talc; iron oxide yellow - arabloc is indicated for the treatment of: active rheumatoid arthritis. active psoriatic arthritis. arabloc is not indicated for the treatment of psoriasis that is not associated with manifestations of arthritic disease. the combined use of arabloc with other disease modifying anti-rheumatic drugs (dmards) has not been adequately studied (see precautions).

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - leflunomide, quantity: 10 mg - tablet, film coated - excipient ingredients: lactose monohydrate; maize starch; povidone; colloidal anhydrous silica; magnesium stearate; crospovidone; hypromellose; macrogol 8000; titanium dioxide; purified talc - arabloc is indicated for the treatment of: active rheumatoid arthritis. active psoriatic arthritis. arabloc is not indicated for the treatment of psoriasis that is not associated with manifestations of arthritic disease. the combined use of arabloc with other disease modifying anti-rheumatic drugs (dmards) has not been adequately studied (see precautions).

United States - English - NLM (National Library of Medicine)

pierrel s.p.a. - articaine hydrochloride (unii: qs9014q792) (articaine - unii:d3sq406g9x), epinephrine bitartrate (unii: 30q7ki53ak) (epinephrine - unii:ykh834o4bh) - articaine hydrochloride 40 mg in 1 ml - orabloc is indicated for local, infiltrative, or conductive anesthesia in both simple and complex dental procedures in adults and pediatric patients 4 years of age and older. orabloc is contraindicated in patients who are hypersensitive to products containing sulfites. products containing sulfites may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. sulfite sensitivity is seen more frequently in asthmatic than in non-asthmatic people [see warnings and precautions (5.5)] . teratogenic effects-pregnancy category c. there are no adequate and well-controlled studies in pregnant women with articaine with epinephrine. articaine hydrochloride and epinephrine (1:100,000) has been shown to increase fetal deaths and skeletal variations in rabbits when given in doses approximately 4 times the maximum recommended human dose (mrhd). orabloc should be used during pregnancy only if the potential benefit justifies the potentia

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - leflunomide -

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - leflunomide -

Canada - English - Health Canada

pierrel s.p.a. - articaine hydrochloride; epinephrine bitartrate - solution - 40mg; 0.009mg - articaine hydrochloride 40mg; epinephrine bitartrate 0.009mg - local anesthetics

Canada - English - Health Canada

pierrel s.p.a. - articaine hydrochloride; epinephrine bitartrate - solution - 40mg; 0.018mg - articaine hydrochloride 40mg; epinephrine bitartrate 0.018mg - local anesthetics

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

pierrel s.p.a.s. s. appia - articaine (articaine hydrochloride), adrenaline (adrenaline tartrate) - solution for injection - 40mg/ml+ 10mcg/ml